Eagle Pharmaceuticals, Inc.
—- Market cap
- —
- Debt
- —
- Cash
- −$55.32M
Complete market value, debt and cash evidence is required for enterprise value.
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
EGRX · price snapshotP/E 0.27x
$0.75Snapshot Sep 2, 2026, 8:00 PM ET
Implied fair value · at BMY's multiple
—
Needs BMY P/E.
BMY · price snapshot
—Price unavailable
Implied fair value · at EGRX's multiple
$0.95
3.46 BMY Annual EPS×0.27x EGRX P/E=$0.95